Angiotensin Receptor Blockers (Arbs) Market Size, Share, Growth Report 2023

The global angiotensin receptor blockers (arbs) market size was valued at USD 8,049.9 million in 2022 and is poised to grow at a significant CAGR of 3.9% during the forecast period 2023-29. The primary drivers of the expansion of the global angiotensin receptor blockers market include the increasing prevalence of cardiovascular diseases and chronic kidney disorders. In addition, increasing geriatric population is expected to boost the growth of angiotensin receptor blockers market.

View the detailed report description here https://www.precisionbusinessinsights.com/market-reports/angiotensin-receptor-blockers-arbs-market

The global angiotensin receptor blockers (arbs) market is segmented based on product, end user, application, and geography.

Based on the product, the market is segmented into the following:
• Valsartan
• Telmisartan
• Losartan
• Irbesartan
• Olmesartan
• Others

Based on the application, the market is segmented into the following:
• Hypertension
• Cardiovascular Diseases
• Kidney Diseases
• Other

Based on the end user, the market is segmented into the following:
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Other

Based on geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

Based on the application, the global Angiotensin Receptor Blockers (ARBs) market is segmented into hypertension, cardiovascular diseases, kidney diseases, and others. The hypertension segment is expected to account for a larger revenue share in the global angiotensin receptor blockers market. The angiotensin receptor blockers are used mainly for the lowering blood pressure and helps in preventing problems related to high blood pressure such as myocardial infraction and stroke. Thus, rising number of populations with hypertension is expected to drive the growth of angiotensin receptor blockers market in this segment over the forecast period.

North America Angiotensin Receptor Blockers (ARBs) Market
The North America angiotensin receptor blockers market is expected to increase over the forecast period due to the increasing prevalence of cardiovascular disease and chronic kidney disorders in this region. In addition, increasing geriatric population who are more prone to these diseases and raising incidence of obesity are expected to boost the market growth in this region over the forecast period. Furthermore, availability of accurate treatment options, early diagnosis process and presence of advanced healthcare infrastructure in this region is expected to further propel the growth of angiotensin receptor blockers in this region over the forecast period.

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players.

The global Angiotensin Receptor Blockers (ARBs) market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In April 2019, FDA published a list of forty angiotensin receptor blockers that are free from three possibly carcinogenic chemicals related to valsartan, losartan among the sartan class of drugs.

Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=757679

Key players profiles in the Angiotensin Receptor Blockers (ARBs) Market report are Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca Plc., GSK Plc., Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Lupin Limited, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy's Laboratories Ltd., Astellas Pharma Inc.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.